References
- Chatterley S N, Jordan G W. Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients. Transplantation 1979; 28: 457–460
- Grundy J, Super M, Sweary P, Moorhead J, Lui S, Berry N, Fernando O, Griffiths P. Symptomatic cytomegalovirus infection in seropositive kidney recipients. Reinfection with donor virus rather than reactivation of recipient virus. Lancet 1988; 2: 132–135
- Helgestrand E, Eriksson B, Johansson N G, Lannerö B, Larsson A, Misioruy A, Norén J, Sjöberg O, Öberg B. Trisodium phosphonoformate, a new antiviral compound. Science 1978; 201: 819–821
- Felenstein D, Damico D J, Hirsch M S. Treatment of cytomegalovirus retinitis with 9-(2-hydroxy-1 hydroxymethyl ethoxymethyl)guanine. Ann Intern Med 1985; 103: 377–380
- Reed E C, Wolford J, Kopecky K, Lilleby K, Dandliker P, Todaro J, McDonald G, Meyers J O. Double-blind randomized trial of ganciclovir for treatment of cytomegalovirus enteritis in marrow transplant patients. Second Int Cytomegalovirus Workshop. San Diego, USA 1989; 64, Abstract, p
- Andersson J, Nybom R, Larson P, Andersson U, Britton S, Ehrnst A. Rapid detection of cytomegalovirus using immune scanning electron microscopy. J Virol Methods 1987; 16: 55–64
- Sundquist V-A, Wahren B. An interchangeable Elisa for cytomegalovirus antigen and antibody. J Virol Methods 1982; 2: 301–312
- Gadler H, Tillegård A, Groth C-G. Studies of cytomegalovirus infection in renal allograft recipients. Scand J Infect Dis 1982; 14: 81–87
- Åkesson-Johansson A, Lernestedt J-O, Ringdén O, Lönnqvist B, Wahren B. Sensitivity of cytomegalovirus to intravenous foscarnet treatment. Bone Marrow Transpl 1986; 1: 215–220
- Wahren B, Harmenberg J, Sundqvist U-A, Levén B, Sköldenberg B. A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds. J Virol Methods 1983; 6: 141–149
- Wahren B, Wahren P, Harmenberg J, Sundqvist U-A. Computer-based virus sensitivity assay and neutralization method. Application to herpesviruses. J Virol Methods 1983; 6: 271–282
- Periera L, Hoffman M, Gallo D, Cremer N. Monoclonal antibodies to human cytomegalovirus; three surface membrane proteins with unique immunological and electrophoretic properties; specify cross reactive determinants. Infect Immun 1982; 36: 924–932
- Ringdén O, Lönnqvist B, Paulin T, Ahlmén J, Klintmalm B, Wahren B, Lernestedt J-O. Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. J Antimicrob Chemother 1986; 17: 373–387
- Ringdén O, Wilcek H, Lönnqvist B, Gahrton G, Wahren B, Lernestedt J-O. Failure to treat interstitial cytomegalovirus pneumonitis with foscarnet. Lancet 1985; 1: 1503–1505
- Ho D D, Rota T R, Andrews C-A, Hirsch M S. Replication of human cytomegalovirus in endothelial cells. N Engl J Med 1984; 150: 956–957
- Bowden R, Dobbs S, Kopecky K, Crawford S, Meyers J. Increased cytotoxicity against cytomegalovirus-infected target cells by broncho-alveolar lavage cells from bone marrow transplant recipients with cytomegalovirus pneumonia. J Infect Dis 1988; 158: 773–779